CSI Market
Sign In | Register

Lava Therapeutics Nv (LVTX) Annual Balance Sheets

Annual · GAAP · USD millions
Access LVTX quarterly Balance Sheets →
The data below summarizes Lava Therapeutics Nv's balance sheet position from to Dec 31 2024, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent35.02
Cash And Cash Equivalents35.00
Short-term Investments, Total41.60
Cash & Short-term Investments111.00
Other Current Assets1.65
Prepaid Expense, Current AS1.07
Total Current Assets79.30
Equipment/Property/Plant Net1.00
Tax Assets, Noncurrent41.51
Other Assets, Noncurrent0.53
Trade And Other Current Receivables-
Current Prepayments And Other Current Assets-
Current Value Added Tax Receivables-
Current Investments-
Trade And Other Current Receivables-
Current Prepayments And Other Current Assets-
Current Value Added Tax Receivables-
Current Heldtomaturity Investments-
Current Investments-
Total Assets80.83
Liabilities
Accounts Payable, Current AC2.72
Accrued Liabilities, Current10.08
Long-term Debt, Current Maturities LO4.89
Other Liabilities, Current10.40
Taxes Payable0.34
Total Current Liabilities18.01
Long-term debt4.89
Total Long-term Debt4.89
Accrued Income Taxes, Noncurrent0.13
Other liabilities, Noncurrent35.08
OperatingLeaseLiabilityNoncurrent0.08
Accrued Liabilities And Other Current Liabilities10.08
Operating Lease Liability Current0.32
Current License Liabilities Research And Development-
Current Contract Liabilities-
Current Accrued Expenses And Other Current Liabilities-
Total Liabilities53.09
Stockholders' Equity
Common Stock Value3.72
Additional Paid In Capital Common Stock211.66
Retained Earnings / Accumulated Deficit-174.97
Accumulated Other Comprehensive Income-12.66
Other Equity-12.66
Common Stockholder's Equity27.75
Total Stockholder's Equity27.75
Liabilities & Stockholder's Equity80.83
4 historic quarters locked

Sign in to unlock the full Lava Therapeutics Nv balance sheet history.

Sign In Create Free Account

About Lava Therapeutics Nv Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-25-003988

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License